These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6090321

  • 1. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    Int J Cancer; 1984 Sep 15; 34(3):339-48. PubMed ID: 6090321
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA.
    IARC Sci Publ; 1985 Sep 15; (60):249-64. PubMed ID: 2998992
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance.
    Rooney CM, Rowe M, Wallace LE, Rickinson AB.
    Nature; 1985 Sep 15; 317(6038):629-31. PubMed ID: 2997615
    [Abstract] [Full Text] [Related]

  • 4. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H, Rowe M, Murray R, Brooks J, Rickinson A.
    Eur J Immunol; 1992 Jul 15; 22(7):1741-8. PubMed ID: 1378014
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul 15; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
    McCormick KH, Giovanella BC, Klein G, Nilsson K, Stehlin JS.
    Int J Cancer; 1981 Oct 15; 28(4):455-8. PubMed ID: 6273332
    [Abstract] [Full Text] [Related]

  • 8. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 15; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 9. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 15; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J, Torsteinsdottir S, Bejarano MT, Klein G, Klein E, Masucci MG.
    Cell Immunol; 1988 Dec 15; 117(2):303-11. PubMed ID: 2848629
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
    Rowe M, Rooney CM, Edwards CF, Lenoir GM, Rickinson AB.
    Int J Cancer; 1986 Mar 15; 37(3):367-73. PubMed ID: 3005176
    [Abstract] [Full Text] [Related]

  • 13. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 15; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 14. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E.
    Cell Immunol; 1986 Apr 01; 98(2):453-66. PubMed ID: 3019570
    [Abstract] [Full Text] [Related]

  • 15. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers.
    Torsteinsdottir S, Masucci MG, Lenoir G, Klein G, Klein E.
    Cell Immunol; 1984 Jul 01; 86(2):278-86. PubMed ID: 6329520
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr 01; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 18. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
    Okano M, Aya T, Mizuno F, Takada K, Osato T.
    Tohoku J Exp Med; 1993 Jun 01; 170(2):71-9. PubMed ID: 8266328
    [Abstract] [Full Text] [Related]

  • 19. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
    Rowe M, Rooney CM, Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA.
    Int J Cancer; 1985 Apr 15; 35(4):435-41. PubMed ID: 2985508
    [Abstract] [Full Text] [Related]

  • 20. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J, Lenoir GM, Fellous M, Lipinski M, Salomon JC, Tetaud C, Tursz T.
    Int J Cancer; 1982 Jun 15; 29(6):653-8. PubMed ID: 6286514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.